– Cognizant and Boehringer Ingelheim collaborate on a unified cloud platform to accelerate the delivery of life-saving therapies
Holistic approach to data management will leverage Veeva’s development cloud
TEANECK, N.J., April 12, 2023/PRNewswire/ — Cognizant (NASDAQ: CTSH) has announced that it is working with Boehringer Ingelheim, a leading research-based biopharmaceutical company, to advance the speed and quality of development of medicinal therapies. Leveraging the Veeva (NYSE: VEEV) Development Cloud, Cognizant will help Boehringer Ingelheim unify drug development processes and data into a connected technology ecosystem, improving collaboration between clinical, regulatory and quality functions.
“Achieving a comprehensive platform to help accelerate the development of life-changing therapies has been an elusive goal for many organizations, and we are making that vision a reality,” said Uli Brӧdl, Senior Vice President, Global Clinical Development, Boehringer Ingelheim. “Our collaborations with Cognizant and Veeva are allowing us to advance this important program that will have a positive impact on the lives of patients.”
Branded “One Medicine Platform,” Boehringer Ingelheim’s connected ecosystem is expected to be one of the largest global implementations of Veeva technology. By simultaneously bringing together Boehringer Ingelheim’s clinical, regulatory and quality functions on this unified platform, this holistic approach is expected to increase interoperability and operational efficiency.
Cognizant kicked off the engagement with Boehringer Ingelheim with an analysis of the biopharmaceutical manufacturer’s business and technology, followed by development of the program roadmap and agile methodology for system integration. In collaboration with Veeva, Cognizant is now implementing the services, which include program management, system architecture and design, training, data migration, integration, testing, and validation services.
“Utilizing advanced technologies to improve the quality and supply of new medicines is a must for innovative pharmaceutical companies, and Boehringer Ingelheim stands out for its forward thinking in developing the One Medicine Platform,” said Srini Shankar, Global Director from Cognizant Life Sciences. “Veeva has been recognized as one of the fastest growing life sciences technology companies, and Cognizant is a qualified systems integrator with the expertise to simultaneously deploy multiple Veeva platforms. We are proud to work together to set new standards. in the way that clinical, regulatory and quality functions come together to help accelerate the delivery of new, life-saving therapies.”
Cognizant was named a Top Veeva Service Provider by analyst firm Everest in 2021.
More information: Cognizant’s Life Sciences Technology Solutions
About Boehringer Ingelheim Boehringer Ingelheim works on revolutionary therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and in family ownership ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve more than 130 markets in the two business units Human Pharma and Animal Health. More information at www.boehringer-ingelheim.com
About Cognizant Cognizant (Nasdaq: CTSH) designs modern businesses. We help our clients modernize technology, reimagine processes, and transform experiences so they can stay ahead in a rapidly changing world. Together, we’re making everyday life better. See how at www.cognizant.com or @cognizant.
For more information, contact:
Cognizant U.S.Josh Blumenthaljoshua.blumenthal@Cognizant.com
Cognizant IndiaRashmi Vasishtrashmi.vasisht@Cognizant.com
Cognizant Europe / APACChristina Schneiderchristina.schneider@cognizant.com
Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/cognizant-y-boehringer-ingelheim-colaboran-en-una-plataforma-en-la-nube-unificada-301795710.html
